Jeffrey S. Glenn
Affiliations: | Gastroenterology | Stanford Medical School, Palo Alto, CA, United States |
Google:
"Jeffrey Glenn"Mean distance: (not calculated yet)
Collaborators
Sign in to add collaborator| Brandon H. Tavshanjian | collaborator | 2009-2011 | Stanford Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hercun J, Heller T, Glenn JS, et al. (2023) Distinct histological patterns in chronic hepatitis D with nucleos(t)ide analogue therapy. Frontiers in Medicine. 10: 1082069 |
| Etzion O, Hamid S, Lurie Y, et al. (2023) Treatment of chronic hepatitis d with peginterferon lambda - the phase 2 LIMT-1 clinical trial. Hepatology (Baltimore, Md.) |
| Mhlanga A, Zakh R, Churkin A, et al. (2022) Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients. Mathematics (Basel, Switzerland). 10 |
| Hassanein T, Tai D, Liu C, et al. (2022) Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial. Evidence-Based Complementary and Alternative Medicine : Ecam. 2022: 4494099 |
| Hercun J, Kim GE, Da BL, et al. (2021) Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapy. Alimentary Pharmacology & Therapeutics |
| Dinnon KH, Leist SR, Schäfer A, et al. (2020) A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures. Nature |
| Fong TL, Lee BT, Chang M, et al. (2020) High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California. Digestive Diseases and Sciences |
| Cho NJ, Glenn JS. (2020) Materials science approaches in the development of broad-spectrum antiviral therapies. Nature Materials |
| Prokunina-Olsson L, Alphonse N, Dickenson RE, et al. (2020) COVID-19 and emerging viral infections: The case for interferon lambda. The Journal of Experimental Medicine. 217 |
| Liu HL, Lv J, Zhao ZM, et al. (2019) Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis. Scientific Reports. 9: 18719 |